📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Comment on "Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration" (2026)

First Author: Malik A

Attributed to: Improving outcomes for patients with hepatocellular carcinoma (HCC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jhep.2025.10.023

Publication URI: http://dx.doi.org/10.1016/j.jhep.2025.10.023

Type: Journal Article/Review

Parent Publication: Journal of Hepatology

Issue: 3